Back to Search
Start Over
Roche announces positive results from phase III study of Gazyva/Gazyvaro in people with lupus nephritis
- Source :
- PharmaBiz. September 27, 2024
- Publication Year :
- 2024
-
Abstract
- Roche announced positive topline results from the phase III REGENCY study of Gazyva/Gazyvaro (obinutuzumab) in people with active lupus nephritis. In the study, a higher proportion of people treated with [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.810326818